Works about PSORIASIS

Results: 5000
    1
    2

    Editor's Picks July 2025.

    Published in:
    Journal of the European Academy of Dermatology & Venereology, 2025, v. 39, n. 7, p. 1203, doi. 10.1111/jdv.20733
    Publication type:
    Article
    3
    4
    5
    6

    Deucravacitinib in plaque psoriasis: Four‐year safety and efficacy results from the Phase 3 POETYK PSO‐1, PSO‐2 and long‐term extension trials.

    Published in:
    Journal of the European Academy of Dermatology & Venereology, 2025, v. 39, n. 7, p. 1336, doi. 10.1111/jdv.20553
    By:
    • Armstrong, April W.;
    • Lebwohl, Mark;
    • Warren, Richard B.;
    • Sofen, Howard;
    • Morita, Akimichi;
    • Paul, Carle;
    • Papp, Kim A.;
    • Colombo, Matthew J.;
    • Scotto, Julie;
    • Vaile, John;
    • Zhuo, Joe;
    • Vritzali, Eleni;
    • Berger, Victoria;
    • Schroeder, Georgene;
    • Banerjee, Subhashis;
    • Thaçi, Diamant;
    • Strober, Bruce
    Publication type:
    Article
    7
    8
    9
    10

    Thesis awards.

    Published in:
    Fundamental & Clinical Pharmacology, 2025, v. 39, p. 1, doi. 10.1111/fcp.70020
    Publication type:
    Article
    11
    12
    13

    Bimekizumab efficacy and safety through 3 years in patients with moderate-to-severe plaque psoriasis: long-term results from the BE RADIANT phase IIIb trial open-label extension period Open Access.

    Published in:
    British Journal of Dermatology, 2025, v. 193, n. 1, p. 44, doi. 10.1093/bjd/ljaf032
    By:
    • Warren, Richard B;
    • Lebwohl, Mark;
    • Thaçi, Diamant;
    • Gooderham, Melinda;
    • Pinter, Andreas;
    • Paul, Carle;
    • Gisondi, Paolo;
    • Szilagyi, Balint;
    • White, Katy;
    • Deherder, Delphine;
    • Staelens, Fabienne;
    • Lambert, Jérémy;
    • Strober, Bruce
    Publication type:
    Article
    14
    15

    The Impact of Metabolic Syndrome on Immune Regulation (IL‐17, IL‐23, and FOXP3+), Psoriasis Severity, Flare Frequency, and Quality of Life in Psoriasis Patients: A Cross‐Sectional Study.

    Published in:
    International Journal of Inflammation, 2025, v. 2025, p. 1, doi. 10.1155/ijin/5855171
    By:
    • Prakoeswa, Flora Ramona Sigit;
    • Maharani, Faradiba;
    • Hidayat, Saiful;
    • Sari, Winda Atika;
    • Oktavriana, Triasari;
    • Prakoeswa, Cita Rosita Sigit;
    • Umborowati, Menul Ayu;
    • Pramuningtyas, Ratih;
    • Bestari, Rochmadina Suci;
    • Aisyah, Riandini;
    • Risanti, Erika Diana;
    • Dewi, Listiana Masyita;
    • Anam, Ilham Hafizha Maulana;
    • Sikora, Mariusz
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27

    Quality of life in mycosis fungoides.

    Published in:
    Baylor University Medical Center Proceedings, 2025, v. 38, n. 4, p. 434, doi. 10.1080/08998280.2025.2505368
    By:
    • Altman, Kirstin;
    • Ha, Oliver
    Publication type:
    Article
    28
    29
    30
    31
    32
    33
    34
    35
    36

    Diagnostic and Therapeutic Challenges in Psoriasis–Atopic Dermatitis Overlap: A Retrospective Observational Cohort Study.

    Published in:
    Diagnostics (2075-4418), 2025, v. 15, n. 11, p. 1381, doi. 10.3390/diagnostics15111381
    By:
    • Brănișteanu, Daciana Elena;
    • Boțoc, Cristina Colac;
    • Huțanu, Antonia Elena;
    • Munteanu, Cătălina Anca;
    • Ciobanu, Roxana Paraschiva;
    • Brănișteanu, Daniel Constantin;
    • Colac, Alin Gabriel;
    • Onu-Brănișteanu, Cătălina Ioana;
    • Brănișteanu, George;
    • Manolache, Nicuta;
    • Porumb-Andrese, Elena;
    • Toader, Mihaela-Paula
    Publication type:
    Article
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49

    PSORIASIS - WHAT'S NEW? SHORT SYNOPSIS.

    Published in:
    Dermatovenerologia Journal, 2025, v. 70, n. 1, p. 33
    By:
    • MIHALACHE, DANIELA;
    • MEHEDINȚI, MIHAELA-CEZARINA;
    • HÎNCU, MARIA-ANDRADA;
    • ONOFREI, ANDREEA;
    • CHELMU-VODĂ, CRISTINA;
    • GURĂU, ALINA-MIHAELA;
    • GAVRILIȚĂ, ELENA;
    • TATU, ALIN LAURENȚIU
    Publication type:
    Article
    50